This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: I-Pex Co., Ltd., Zeria Pharmaceutical Co., Ltd.. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Fukuoka, JP (2010)
- Tokyo, JP (2009 - 2013)
Company Filing History:
Years Active: 2009-2013
Title: The Innovations of Kouichirou Tanaka: Pioneering Therapeutic Solutions in Tokyo
Introduction
Kouichirou Tanaka is a notable inventor based in Tokyo, Japan, renowned for his contributions to the field of pharmaceutical innovations. With a total of four patents, Tanaka has focused primarily on developing compounds aimed at treating systemic wasting diseases. His innovative approach combines chemical expertise with a driven desire to improve health outcomes for individuals suffering from such conditions.
Latest Patents
Tanaka's latest patents revolve around the development of 3,8-diaminotetrahydroquinoline derivatives. The first patent outlines a method for treating systemic wasting diseases by administering an effective amount of a 3,8-diaminotetrahydroquinoline derivative. The compound is designed with a complex chemical structure, including various groups that indicate its effectiveness and versatility in therapeutic applications.
The second patent reveals a compound with potent agonistic activity on GHS-R, aimed specifically at addressing cachexia and its related complications. This innovative 3,8-diaminotetrahydroquinoline derivative's structure is also well-detailed, showcasing a variety of substituents and configurations to enhance therapeutic potential.
Career Highlights
Throughout his career, Kouichirou Tanaka has collaborated with several esteemed organizations, including I-Pex Co., Ltd. and Zeria Pharmaceutical Co., Ltd. His work in these companies has allowed him to refine his skills in drug development and chemical synthesis, contributing significantly to advancements in health solutions.
Collaborations
Tanaka has collaborated with prominent colleagues, including Takeshi Watanabe and Masaru Terauchi, who have shared his passion for innovation in the pharmaceutical industry. These collaborations have further enriched his research endeavors and facilitated the successful development of his innovative compounds.
Conclusion
In conclusion, Kouichirou Tanaka stands as a significant figure in the realm of pharmaceutical inventions. His pursuit of innovative solutions for systemic wasting diseases reflects his commitment to improving healthcare outcomes. With a proven track record of patents and collaborative endeavors, Tanaka continues to be an influential presence in the field of drug development in Japan.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile